Bloomage Biotech is a biotechnology company driven by innovative synthetic biology technology, with an integrated platform covering the full value chain of biological materials.
Founded in 2000, Bloomage Biotech is a world-leading biotechnology and biomanufacturing enterprise. We were the first company globally to achieve industrial-scale production of hyaluronic acid (HA), a core anti-aging ingredient, and have maintained a leading global market position for years. Building on our strengths in HA R&D, we conduct advanced research in glycobiology and cell biology. Leveraging the world’s largest synthetic biomanufacturing platform, Bloomage Biotech is committed to translating life science research into practical applications in aging intervention, tissue regeneration, and related fields. We have developed an integrated solution spanning from raw materials to finished products, covering pharmaceuticals, medical aesthetics, nutrition science, and skin science. Our brand portfolio includes BIOHYALUX, QUADHA, MedRepair, Bio-MESO, and Bloomage Health.
Guided by our mission to “Make every life vibrant,” we continuously advance the health and beauty industries.